advertisement
Ishida S 11
Showing records 1 to 11 |
Display all abstracts from Ishida S106022 Reduction of Intraocular Pressure and Aqueous Outflow Resistance after Modified 360-degree Suture TrabeculotomySuzuki K
Journal of Glaucoma 2023; 32: 204-209
106284 Two-year clinical outcomes of triple therapy with photodynamic therapy, anti-vascular endothelial growth factor agent, and triamcinolone acetonide for neovascular age-related macular degenerationAndo R
Japanese Journal of Ophthalmology 2023; 67: 50-58
106022 Reduction of Intraocular Pressure and Aqueous Outflow Resistance after Modified 360-degree Suture TrabeculotomyShinmei Y
Journal of Glaucoma 2023; 32: 204-209
106284 Two-year clinical outcomes of triple therapy with photodynamic therapy, anti-vascular endothelial growth factor agent, and triamcinolone acetonide for neovascular age-related macular degenerationHirooka K; Saito M
Japanese Journal of Ophthalmology 2023; 67: 50-58
106022 Reduction of Intraocular Pressure and Aqueous Outflow Resistance after Modified 360-degree Suture TrabeculotomyHirooka K
Journal of Glaucoma 2023; 32: 204-209
106284 Two-year clinical outcomes of triple therapy with photodynamic therapy, anti-vascular endothelial growth factor agent, and triamcinolone acetonide for neovascular age-related macular degenerationKase S
Japanese Journal of Ophthalmology 2023; 67: 50-58
106022 Reduction of Intraocular Pressure and Aqueous Outflow Resistance after Modified 360-degree Suture TrabeculotomyKanaya R; Shinkai A
Journal of Glaucoma 2023; 32: 204-209
106284 Two-year clinical outcomes of triple therapy with photodynamic therapy, anti-vascular endothelial growth factor agent, and triamcinolone acetonide for neovascular age-related macular degenerationNoda K
Japanese Journal of Ophthalmology 2023; 67: 50-58
106022 Reduction of Intraocular Pressure and Aqueous Outflow Resistance after Modified 360-degree Suture TrabeculotomyKijima R
Journal of Glaucoma 2023; 32: 204-209
106284 Two-year clinical outcomes of triple therapy with photodynamic therapy, anti-vascular endothelial growth factor agent, and triamcinolone acetonide for neovascular age-related macular degenerationIshida S
Japanese Journal of Ophthalmology 2023; 67: 50-58
106022 Reduction of Intraocular Pressure and Aqueous Outflow Resistance after Modified 360-degree Suture TrabeculotomyChin S; Ito YM; Ishida S
Journal of Glaucoma 2023; 32: 204-209
Issue 23-3
Change Issue
advertisement